Anuh Pharma Ltd.
NSE: ANUHPHR | BSE: 506260
₹75.58
₹-0.59
(-0.77%)
As on 22-May-2026IST
Market cap
₹763 Cr
Revenue (TTM)
₹772 Cr
P/E Ratio
18.6
P/B Ratio
2.2
Div. Yield
2 %
Quality Score
5/10
Growth Score
6/10
Valuation Score
6/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹41 Cr
-
ROE
15.3 %
-
ROCE
19.8 %
-
Industry P/E
38.63
-
EV/EBITDA
11.4
-
Debt to Equity
0
-
Book Value
₹35.1
-
EPS
₹4.9
-
Face value
5
-
Shares outstanding
100,224,000
10 Years Aggregate
CFO
₹214.58 Cr
EBITDA
₹413.42 Cr
Net Profit
₹302.63 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anuh Pharma
| -6.1 | -6.4 | 0.8 | -28.5 | -- | -- | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
|---|---|
|
Anuh Pharma
| -30.3 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Anuh Pharma
|
75.6 | 762.8 | 771.7 | 41.1 | 6.2 | 12.1 | 18.6 | 2.2 |
| 390.0 | 3,555.0 | 2,565.3 | 194.9 | 9.4 | 12.9 | 18.2 | 2.3 | |
| 1,039.0 | 12,715.2 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.5 | 3.8 | |
| 1,713.6 | 32,463.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.1 | 6.6 | |
| 118.7 | 3,486.8 | 2,319.1 | 137.6 | 8.1 | 8.2 | 25.3 | 1.9 | |
| 16,693.0 | 21,341.3 | 2,023.0 | 364.0 | 23.9 | 20.8 | 58.6 | 11.4 | |
| 2,293.9 | 3,802.3 | 707.5 | 115.2 | 17.8 | 19.4 | 33 | -- | |
| 1,111.0 | 5,114.0 | 649.5 | 121.6 | 23.7 | 13.2 | 44.3 | 5.5 | |
| 548.1 | 2,643.3 | 1,369.0 | -7.4 | 6.4 | -0.1 | -- | 2.1 | |
| 265.5 | 7,015.0 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Stock Rating update, April 08, 2024
1 min read•By Value Research
About Anuh Pharma
Anuh Pharma Limited manufactures and sells pharmaceuticals, medicinal chemicals, and botanical products in India. The company offers active pharmaceutical ingredients, such as macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, and... expectorant, quinolones, and intermediates. It also provides corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, and anti-histamines. The company also exports its products. Anuh Pharma Limited was founded in 1960 and is headquartered in Mumbai, India. Read more
-
Incorporated
1960
-
Chairman
Arun Todarwal
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Anuh Pharma
What is the current share price of Anuh Pharma Ltd Today?
The share price of Anuh Pharma Ltd is ₹75.58 (NSE) and ₹76.11 (BSE) as of 22-May-2026 IST. Anuh Pharma Ltd has given a return of -28.48% in the last 1 years.
What is the current PB & PE ratio of Anuh Pharma Ltd?
The P/E ratio of Anuh Pharma Ltd is 18.58 times as on 22-May-2026, a 52 discount to its peers’ median range of 38.63 times.
The P/B ratio of Anuh Pharma Ltd is 2.17 times as on 22-May-2026, a 6 discount to its peers’ median range of 2.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
7.88
|
2.29
|
|
2024
|
10.25
|
4.23
|
|
2023
|
11.03
|
1.65
|
|
2022
|
14.09
|
2.01
|
|
2021
|
15.91
|
2.37
|
What is the 52 Week High and Low of Anuh Pharma Ltd?
The 52-week high and low of Anuh Pharma Ltd are Rs 114.90 and Rs 67.00 as of 23-May-2026.
What is the market cap of Anuh Pharma Ltd?
Anuh Pharma Ltd has a market capitalisation of ₹ 763 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Anuh Pharma Ltd?
Before investing in Anuh Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.